562 related articles for article (PubMed ID: 31619297)
1. CT radiomic features for predicting resectability of oesophageal squamous cell carcinoma as given by feature analysis: a case control study.
Ou J; Li R; Zeng R; Wu CQ; Chen Y; Chen TW; Zhang XM; Wu L; Jiang Y; Yang JQ; Cao JM; Tang S; Tang MJ; Hu J
Cancer Imaging; 2019 Oct; 19(1):66. PubMed ID: 31619297
[TBL] [Abstract][Full Text] [Related]
2. Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy.
Tang S; Ou J; Liu J; Wu YP; Wu CQ; Chen TW; Zhang XM; Li R; Tang MJ; Yang LQ; Tan BG; Lu FL; Hu J
Cancer Imaging; 2021 May; 21(1):38. PubMed ID: 34039403
[TBL] [Abstract][Full Text] [Related]
3. CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy.
Yang Z; He B; Zhuang X; Gao X; Wang D; Li M; Lin Z; Luo R
J Radiat Res; 2019 Jul; 60(4):538-545. PubMed ID: 31111948
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced CT-based radiomic analysis for determining the response to anti-programmed death-1 therapy in esophageal squamous cell carcinoma patients: A pilot study.
Yang Q; Huang H; Zhang G; Weng N; Ou Z; Sun M; Luo H; Zhou X; Gao Y; Wu X
Thorac Cancer; 2023 Nov; 14(33):3266-3274. PubMed ID: 37743537
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced CT radiomics features to predict recurrence of locally advanced oesophageal squamous cell cancer within 2 years after trimodal therapy: A case-control study.
Tang S; Ou J; Wu YP; Li R; Chen TW; Zhang XM
Medicine (Baltimore); 2021 Jul; 100(27):e26557. PubMed ID: 34232198
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced CT radiomics features to preoperatively identify differences between tumor and proximal tumor-adjacent and tumor-distant tissues of resectable esophageal squamous cell carcinoma.
Gao D; Tan BG; Chen XQ; Zhou C; Ou J; Guo WW; Zhou HY; Li R; Zhang XM; Chen TW
Cancer Imaging; 2024 Jan; 24(1):11. PubMed ID: 38243339
[TBL] [Abstract][Full Text] [Related]
7. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
8. Computed tomography-based radiomic analysis for prediction of treatment response to salvage chemoradiotherapy for locoregional lymph node recurrence after curative esophagectomy.
Gu L; Liu Y; Guo X; Tian Y; Ye H; Zhou S; Gao F
J Appl Clin Med Phys; 2021 Nov; 22(11):71-79. PubMed ID: 34614265
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Prediction of Perineural Invasion in Oesophageal Squamous Cell Carcinoma Based on CT Radiomics Nomogram: A Multicenter Study.
Zhou H; Zhou J; Qin C; Tian Q; Zhou S; Qin Y; Wu Y; Shi J; Feng F
Acad Radiol; 2024 Apr; 31(4):1355-1366. PubMed ID: 37949700
[TBL] [Abstract][Full Text] [Related]
10. Combining the radiomic features and traditional parameters of
Chen YH; Lue KH; Chu SC; Chang BS; Wang LY; Liu DW; Liu SH; Chao YK; Chan SC
Ann Nucl Med; 2019 Sep; 33(9):657-670. PubMed ID: 31218571
[TBL] [Abstract][Full Text] [Related]
11. Prediction of response after chemoradiation for esophageal cancer using a combination of dosimetry and CT radiomics.
Jin X; Zheng X; Chen D; Jin J; Zhu G; Deng X; Han C; Gong C; Zhou Y; Liu C; Xie C
Eur Radiol; 2019 Nov; 29(11):6080-6088. PubMed ID: 31028447
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a radiomic nomogram based on pretherapy dual-energy CT for distinguishing adenocarcinoma from squamous cell carcinoma of the lung.
Chen Z; Yi L; Peng Z; Zhou J; Zhang Z; Tao Y; Lin Z; He A; Jin M; Zuo M
Front Oncol; 2022; 12():949111. PubMed ID: 36505773
[TBL] [Abstract][Full Text] [Related]
13. Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers.
Zhu Y; Yao W; Xu BC; Lei YY; Guo QK; Liu LZ; Li HJ; Xu M; Yan J; Chang DD; Feng ST; Zhu ZH
BMC Cancer; 2021 Oct; 21(1):1167. PubMed ID: 34717582
[TBL] [Abstract][Full Text] [Related]
14. CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
Yan S; Li FP; Jian L; Zhu HT; Zhao B; Li XT; Shi YJ; Sun YS
BMC Cancer; 2023 May; 23(1):477. PubMed ID: 37231388
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Locoregional Recurrence-Free Survival of Oesophageal Squamous Cell Carcinoma After Chemoradiotherapy Based on an Enhanced CT-Based Radiomics Model.
Kong J; Zhu S; Shi G; Liu Z; Zhang J; Ren J
Front Oncol; 2021; 11():739933. PubMed ID: 34631575
[TBL] [Abstract][Full Text] [Related]
16. The MR radiomic signature can predict preoperative lymph node metastasis in patients with esophageal cancer.
Qu J; Shen C; Qin J; Wang Z; Liu Z; Guo J; Zhang H; Gao P; Bei T; Wang Y; Liu H; Kamel IR; Tian J; Li H
Eur Radiol; 2019 Feb; 29(2):906-914. PubMed ID: 30039220
[TBL] [Abstract][Full Text] [Related]
17. Radiomics and dosiomics for predicting complete response to definitive chemoradiotherapy patients with oesophageal squamous cell cancer using the hybrid institution model.
Kawahara D; Murakami Y; Awane S; Emoto Y; Iwashita K; Kubota H; Sasaki R; Nagata Y
Eur Radiol; 2024 Feb; 34(2):1200-1209. PubMed ID: 37589902
[TBL] [Abstract][Full Text] [Related]
18. Predicting Lymph Node Metastasis Using Computed Tomography Radiomics Analysis in Patients With Resectable Esophageal Squamous Cell Carcinoma.
Zhao B; Zhu HT; Li XT; Shi YJ; Cao K; Sun YS
J Comput Assist Tomogr; 2021 Mar-Apr 01; 45(2):323-329. PubMed ID: 33512851
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography-based radiomics analysis to predict lymphovascular invasion in esophageal squamous cell carcinoma.
Peng H; Yang Q; Xue T; Chen Q; Li M; Duan S; Cai B; Feng F
Br J Radiol; 2022 Feb; 95(1130):20210918. PubMed ID: 34908477
[TBL] [Abstract][Full Text] [Related]
20. Computed tomography-based radiomic analysis for predicting pathological response and prognosis after neoadjuvant chemotherapy in patients with locally advanced esophageal cancer.
Oda S; Kuno H; Hiyama T; Sakashita S; Sasaki T; Kobayashi T
Abdom Radiol (NY); 2023 Aug; 48(8):2503-2513. PubMed ID: 37171586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]